{
  "id": 12863780,
  "title": "Stanford blood cancer transplant therapy reaches first commercial patient",
  "url": "https://urgent.news/2026/10/08/stanford-blood-cancer-transplant-therapy-reaches-first-commercial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T11:30:00.000Z",
  "source": {
    "name": "Times of India",
    "slug": "times-of-india",
    "url": "https://timesofindia.indiatimes.com/science/discovery/stanford-spent-more-than-20-years-developing-a-blood-cancer-transplant-therapy-its-first-commercial-patient-has-now-been-treated-after-a-trial-found-78-were-free-from-moderate-to-severe-gvhd-at-one-year/articleshow/134788057.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative treatment was administered to its inaugural commercial patient, a high-risk leukemia sufferer. Notably, Orca-T significantly minimizes the chances of graft-versus-host disease post-stem cell transplants, offering…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}